20 May 2013
Keywords: novartis, annual, day, highlights, ahead-of-schedule, submissions, fda
Article | 04 December 2006
At its annual R&D day, held in London, UK, Swiss drug major Novartis reported that a number of compounds ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 December 2006
17 May 2013
© 2013 thepharmaletter.com